C.F.R. homeSearch C.F.R.
C.F.R.Title 21Chapter I—Food and Drug Administration, Department of Health and Human ServicesSubchapter D—Drugs for Human UsePart 341—Cold, Cough, Allergy, Bronchodilator, And Antiasthmatic Drug Products for Over-The-Counter Human UseSubpart B—Active Ingredients

21 C.F.R. § 341.20 (2026)

Nasal decongestant active ingredients

Edition and currency
eCFR text as of Sept. 29, 2026. The text is the edition Syfert holds; for a past event, check the version in force on that date.
Other sources
CURRENTeCFR text as of Sept. 29, 2026 cited 2004–2008 2citing cases
At a glance

Courts have cited this section in 2 opinions since 2004.

The active ingredient of the product consists of any of the following when used within the dosage limits and in the dosage forms established for each ingredient:

(a) Oral nasal decongestants. (1) Phenylephrine hydrochloride.

(2) Pseudoephedrine hydrochloride.

(3) Pseudoephedrine sulfate.

(4) Phenylephrine bitartrate in an effervescent dosage form.

(b) Topical nasal decongestants. (1) Levmetamfetamine.

(2) Ephedrine.

(3) Ephedrine hydrochloride.

(4) Ephedrine sulfate.

(5) [Reserved]

(6) Naphazoline hydrochloride.

(7) Oxymetazoline hydrochloride.

(8) Phenylephrine hydrochloride.

(9) Propylhexedrine.

(10) Xylometazoline hydrochloride.

[59 FR 43409, Aug. 23, 1994, as amended at 63 FR 40650, July 30, 1998; 71 FR 43362, Aug. 1, 2006]
The 2 cases that cite 21 C.F.R. § 341.20 most heavily, weighted by court and treatment. RelevanceNewestTreatment
1
GREENPrince v. BF Ascher Co., 2004 OK CIV APP 39, 90 P.3d 1020.
cites § 341.20 1×cited by 23 cases
Where it cites § 341.20
“21 C.F.R. § 341.20 (b)(9). It classifies Benze-drex® a nonnareotic product that may be sold without a prescription.”
Later courts cite it for
“(1) the product was the cause of the injury; (2) the defect existed in the product at the time it left the manufacturer's possession and control (if the action is against the manufacturer) or at the time of sale for public use (if the action is against the retailer or supplier); and (3) the defect made the article 'unreasonably dangerous' to plaintiff or his property, meaning dangerous to an extent beyond that which would be contemplated by the ordinary consumer who purchases the product with the ordinary knowledge common to the community as to its characteristics.” · 2 citing courts
2
GREENIndep. Cnty. v. Pfizer, Inc., 534 F. Supp. 2d 882 (E.D. Ark. 2008).
cites § 341.20 1×cited by 5 cases
Where it cites § 341.20
“(B) Subdivision (a)(l!)(A) of this section does not apply to the transmission of a caller identification service by a telecommunications provider, (b) The deceptive and unconscionable trade practices listed in this section are in addition to and do not limit the types of unfair…”
Later courts cite it for
“the arkansas supreme court defined an unconscionable act as 'an act that affronts the sense of justice, decency, or reasonableness' including acts that violate public policy or a statute.” · 2 citing courts

The flag is Syfertize’s treatment of the citing case itself, not of the statute. “Where it cites” is the passage in the opinion; the holding is a summary of the whole case and may concern another point. Annotations are extracted automatically from the opinions in the Syfert caselaw corpus.

By subsection

Courts have not cited this section by subsection, so its cases are not split up here. The Leading cases tab lists the cases that cite it most heavily.

Enactment and amendments

Syfert holds no separate history line for this section. Where this code prints a source or history note, it appears with the text, usually at the end.

Versions

Edition shown: eCFR text as of Sept. 29, 2026. Syfert holds no earlier or later version of this section.

C.F.R. Home  |  Search C.F.R.  |  Search cases for this section  |  syfert.com